(Q24298750)

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

PIDD mediates NF-kappaB activation in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Shared principles in NF-kappaB signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

TNF-alpha induces two distinct caspase-8 activation pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Chemokine signaling via the CXCR2 receptor reinforces senescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

RIP kinases at the crossroads of cell death and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kappaB inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The DNA damage response: ten years after

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The ATM-mediated DNA-damage response: taking shape.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The death domain kinase RIP mediates the TNF-induced NF-kappaB signal

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

PUMA, a novel proapoptotic gene, is induced by p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

A unified model for apical caspase activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Regulation of death receptor signaling by the ubiquitin system

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

RIPK1 is not essential for TNFR1-induced activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Cell-cycle checkpoints and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Nuclear factor-kappaB in cancer development and progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The DNA-damage response in human biology and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

A small molecule-kinase interaction map for clinical kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

A quantitative analysis of kinase inhibitor selectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

SASPense and DDRama in cancer and ageing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Identification of RIP1 kinase as a specific cellular target of necrostatins

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

NF-kappaB at the crossroads of life and death

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Death receptor signal transducers: nodes of coordination in immune signaling networks

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The role of double-strand break repair — insights from human genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The CD95(APO-1/Fas) DISC and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Signals from within: the DNA-damage-induced NF-kappaB response

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The ATM protein is required for sustained activation of NF-kappaB following DNA damage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Parallel induction of ATM-dependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Effects of NF-kappaB1 (p50) targeted gene disruption on ionizing radiation-induced NF-kappaB activation and TNFalpha, IL-1alpha, IL-1beta and IL-6 mRNA expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

TNF-R1 signaling: a beautiful pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Cell biology. The stress of finding NEMO.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

The interleukin-8 pathway in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021

Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CELL.2011.02.023

7 January 2021